Claritas Axis Launches Free FDA Compliance Readiness Tool as Enforcement Rises

New assessment helps medical practices identify drug supply chain documentation gaps before regulators do.

Apr. 1, 2026 at 1:52pm

Got story updates? Submit your updates here. ›

Claritas Axis, a compliance platform for physician-owned practices, has launched a free FDA Compliance Readiness Snapshot to help medical practices assess their documentation for purchasing and administering prescription drugs. The launch comes as federal and state regulators increase inspections and enforcement actions against practices with gaps in their drug supply chain records.

Why it matters

The FDA and state regulators have been actively inspecting physician-owned practices, issuing citations, fines, and license suspensions when required drug documentation cannot be produced. This new free assessment tool from Claritas Axis aims to help practices identify and address compliance gaps before facing regulatory action.

The details

The Claritas Axis FDA Compliance Readiness Snapshot is a free, 10-question assessment that evaluates a practice's compliance with the Drug Supply Chain Security Act (DSCSA). The assessment covers areas like purchase records, product traceability, and vendor authorization documentation. Practices receive an instant risk score and can access a more detailed $99 assessment if significant gaps are identified.

  • In January 2026, the FDA issued its first Form 483 citation against a physician-owned med spa in Texas for drug purchasing and documentation failures.
  • In June 2025, the FDA finalized its Remote Regulatory Assessment framework, allowing inspections to begin before an investigator arrives on-site.

The players

Claritas Axis

A compliance platform that provides assessment tools, documentation, training, and support for physician-owned medical practices to meet FDA drug supply chain requirements.

U.S. Food and Drug Administration (FDA)

The federal agency responsible for regulating and supervising the safety of food, drugs, and medical devices, including enforcing the Drug Supply Chain Security Act (DSCSA).

Got photos? Submit your photos here. ›

What they’re saying

“We pride ourselves on running a compliant practice, Claritas Axis FDA Readiness Snapshot still found three documentation gaps we hadn't recognized. It took five minutes and changed how we operate.”

— Jerri Hirst, Owner, JKH Aesthetics; Host, The Beauty Outlaw Podcast

“Most practices that fail these inspections don't fail because of intent. They fail because they have never been asked to produce this documentation before.”

— James Strafuss, Founder, Claritas Axis

“This is not a niche compliance issue - it is critical information for every practice administering prescription drug products, and the solution Claritas has built is exactly what this industry needs right now.”

— Clay Daniells, CEO, QooQoo; Marketing firm serving the aesthetics and eyecare industries

What’s next

The FDA is scheduled to present on its first formal inspection and Form 483 citation against a physician-owned aesthetics practice at the American Med Spa Association's Medical Spa Show 2026 on April 11. This is expected to prompt many practice owners to seek compliance solutions like the Claritas Axis Readiness Snapshot.

The takeaway

As federal and state regulators increase enforcement of drug supply chain documentation requirements, medical practices that administer prescription drugs must proactively assess and address any compliance gaps to avoid citations, fines, and potential license suspensions. The Claritas Axis Readiness Snapshot provides a quick and easy way for practices to identify problem areas before facing regulatory action.